{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:35Z","timestamp":1771054475608,"version":"3.50.1"},"reference-count":90,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004052","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T22:16:55Z","timestamp":1069453015000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Valproate for acute mood episodes in bipolar disorder"],"prefix":"10.1002","author":[{"given":"Karine","family":"Macritchie","sequence":"first","affiliation":[{"name":"King\u2019s College; c\/o Ms Caroline Loveland, Centre for Affective Disorders, Institute of Psychiatry; Denmark Hill London UK SE5 8AF"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"University of Oxford\/Warneford Hospital; Department of Psychiatry; Oxford UK OX3 7JX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Scott","sequence":"additional","affiliation":[{"name":"Newcastle University; Academic Psychiatry; Newcastle Upon Tyne UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D R","family":"Haslam","sequence":"additional","affiliation":[{"name":"University of British Columbia; Department of Psychiatry; Vancouver BC Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Silva de Lima","sequence":"additional","affiliation":[{"name":"Genentech; US Medical Affairs; 1 DNA Way South San Francisco California USA 94080-4990"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Goodwin","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Department of Psychiatry Warneford Hospital Oxford Oxon UK OX3 7JX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,1,20]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD004052-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004052-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<26::AID-DA4>3.0.CO;2-3","article-title":"Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania","volume":"6","author":"Bowden","year":"1997","journal-title":"Depression & Anxiety"},{"key":"10.1002\/14651858.CD004052-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relation of serum valproate concentration to response in mania","volume":"153","author":"Bowden","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-3223(95)00141-7","article-title":"Plasma GABA predicts acute response to divalproex in mania","volume":"39","author":"Petty","year":"1996","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania: treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00004714-199202001-00003","article-title":"Dysphoric mania","volume":"12","author":"Clothier","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004052-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"A double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004052-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4088\/JCP.v60n1202","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004052-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0010|cit10","first-page":"142","article-title":"A randomised comparison of divalproex loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004052-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-200004000-00012","article-title":"Valproate add-on therapy in acute manic episodes. A prospective, randomised, double-blind, placebo-controlled multicentre study","volume":"20","author":"Muller-Oerlinghausen","year":"2000","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania: A placebo controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0013|cit13","unstructured":"Tohen M Baker RW Altshuler L Zarate CA Ketter TA Milton DR Olanzapine versus divalproex for ther treatment of acute mania Stanley Foundation Conference on Bipolar Disorder September 21-22 2000 Amsterdam 2000"},{"key":"10.1002\/14651858.CD004052-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130000380","article-title":"Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder","volume":"150","author":"Vasudev","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder","volume":"63","author":"Zajecka","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0016|cit16","first-page":"297","article-title":"Valpromide (Depamide) in the treatment of acute psychotic states: An open clinical study","volume":"86","author":"Altamura","year":"1986","journal-title":"Acta Psychiatrica Belgica"},{"key":"10.1002\/14651858.CD004052-BIB0017|cit17","first-page":"1","article-title":"Treatment of mania with valproic acic: an open study","volume":"150","author":"Berney","year":"1999","journal-title":"Schweizer archive fur neurologie und psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD004052-BIB0018|cit18","first-page":"118","article-title":"Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study","volume":"56","author":"Brady","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0019|cit19","first-page":"56","article-title":"Anticonvulsants in affective disorders","volume-title":"Excerpta Medica","author":"Brennan","year":"1984"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/ajp.147.4.431","article-title":"Spectrum of efficacy of valproate in 55 patients with rapid-cycling disorder","volume":"147","author":"Calabrese","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00004714-199202001-00008","article-title":"Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients","volume":"12","author":"Calabrese","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004052-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4088\/JCP.v60n0306","article-title":"Efficacy of lithium versus valproate in the treatment of mania in the elderly: A retrospective study","volume":"16","author":"Chen","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0023|cit23","first-page":"647","article-title":"Valproate as an antidepressant in major depressive disorder","volume":"32","author":"Davis","year":"1996","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004052-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0447.1998.tb09994.x","article-title":"Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients","volume":"97","author":"Deltito","year":"1998","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD004052-BIB0025|cit25","first-page":"563","article-title":"The comparative efficacy of divalproex low and high serum level in bipolar disorder and schizophrenia","volume":"31","author":"Ellenor","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004052-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","article-title":"The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders","volume":"8","author":"Emrich","year":"1985","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004052-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4088\/JCP.v63n0511","article-title":"Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: A double-blind placebo-controlled pilot study","volume":"63","author":"Frankenburg","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4088\/JCP.v59n0402","article-title":"Rapid titration of mood stabilisers predicts remission from mixed or pure mania in bipolar patients","volume":"59","author":"Goldberg","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004052-BIB0029|cit29","first-page":"204","article-title":"Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium","volume":"57","author":"Granneman","year":"1996","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD004052-BIB0030|cit30","first-page":"35","article-title":"Long term use of valproate in primary psychiatric disorders","volume":"50","author":"Hayes","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004052-BIB0031|cit31","first-page":"229","article-title":"Low dose valproate: A new treatment for cyclothymia, mild rapid cycling disorders and premenstrual syndrome","volume":"54","author":"Jacobsen","year":"1993","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0032|cit32","first-page":"276","article-title":"Synergy of carbamazepine and valproic acid in affective illness: A case report and literature review","volume":"12","author":"Ketter","year":"1992","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0033|cit33","first-page":"33","article-title":"Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide)","volume-title":"Anticonvulsants in affective disorders","author":"Lambert","year":"1984"},{"key":"10.1002\/14651858.CD004052-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0165-0327(98)00065-2","article-title":"A naturalistic comparison of adverse effects between slow titration and loading of divalproex sodium in psychiatric inpatients","volume":"52","author":"Lima","year":"1999","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004052-BIB0035|cit35","first-page":"479","article-title":"Valproate use in the older manic patient","volume":"51","author":"McFarland","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004052-BIB0036|cit36","first-page":"16","article-title":"Sodium valproate: its use in primary psychiatric disorders","volume":"7","author":"McElroy","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004714-198808000-00007","article-title":"Valproate in the treatment of rapid-cycling bipolar disorder","volume":"8","author":"McElroy","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD004052-BIB0038|cit38","first-page":"213","article-title":"Divalproex sodium treatment in late adolescent and young adult acute mania","volume":"29","author":"Papatheodorou","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD004052-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004714-199504000-00006","article-title":"The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults:an open clinical trial,","volume":"15","author":"Papatheodorou","year":"1995","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-0327(84)90013-2","article-title":"Valproic acid amide in the treatment of affective and schizoaffective disorders","volume":"6","author":"Puzynski","year":"1984","journal-title":"Journal of Affective Disorders"},{"issue":"9","key":"10.1002\/14651858.CD004052-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1176\/ps.49.9.1145","article-title":"Use of mood stabilisers by hospitalised geriatric patients with bipolar disorder","volume":"49","author":"Sanderson","year":"1998","journal-title":"Psychiatric Services"},{"issue":"10","key":"10.1002\/14651858.CD004052-BIB0042|cit42","first-page":"380","article-title":"Divalproex sodium in the treatment of refractory affective disorders","volume":"54","author":"Schaff","year":"1993","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0043|cit43","first-page":"201","article-title":"Valproate augmentation in lithium-resistant rapid-cycling mania in four geriatric patients","volume":"47","author":"Schneider","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0044|cit44","first-page":"458","article-title":"A clinical study of the mood stabilising effect of dipropylacetamide","volume":"76","author":"Semadeni","year":"1976","journal-title":"Acta Psychiatrica Belgica"},{"issue":"18","key":"10.1002\/14651858.CD004052-BIB0045|cit45","first-page":"1069","article-title":"Sodium di-n-propylacetate: evalutation of its so-called psychotropic effect","volume":"139","author":"Sommerbeck","year":"1977","journal-title":"Ugeskr-Laeger"},{"issue":"1","key":"10.1002\/14651858.CD004052-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0011-393X(01)80042-4","article-title":"Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial","volume":"62","author":"Tariot","year":"2001","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD004052-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/cap.1994.4.263","article-title":"Open trial of valproate in the treatment of adolescent mania","volume":"4","author":"West","year":"1994","journal-title":"Journal of Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Giannini AJ Sullivan BS Folts DJ Comparison of lithium carbonate, valproic acid and verapamil in the treatment of manic symptoms Abstracts from the Eighteenth Annual Meeting of the American College of Clinical Pharmacology. Journal of Clinical Pharmacology 1989 832","DOI":"10.1002\/j.1552-4604.1989.tb03429.x"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004052-BIB0049|cit49","first-page":"A19; B4","article-title":"Comparative efficacy and tolerability of lithium, carbamazepine and valproate in acute mania","volume":"15","author":"Goswami","year":"2001","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0050|cit50","first-page":"367","article-title":"Utilisation de valpromide en therapeutique psychiatrique","volume":"13","author":"Lambert","year":"1987","journal-title":"Encephale"},{"issue":"8","key":"10.1002\/14651858.CD004052-BIB0051|cit51","first-page":"335","article-title":"The therapeutic effect of sodium valproate and carbamazepine in mania.","volume":"13","author":"Morinigo","year":"1992","journal-title":"Psiquis"},{"key":"10.1002\/14651858.CD004052-BIB0052|cit52","first-page":"86","article-title":"Double-blind placebo controlled study of valproate in treating lithium-resistant mania","volume":"21","author":"Tiangin","year":"1995","journal-title":"Chinese Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004052-BIB0054|cit54","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD004052-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0056|cit56","first-page":"182","article-title":"Anticonvulsants","volume-title":"Meyler's side effects of drugs. An encyclopaedia of adverse reactions and interactions","author":"Battino","year":"1996"},{"issue":"8","key":"10.1002\/14651858.CD004052-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomised controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD004052-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00023210-200115110-00005","article-title":"Olanzapine: A review of its use in the treatment of bipolar I disorder","volume":"15","author":"Bhana","year":"2001","journal-title":"CNS Drugs"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD004052-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004052-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004052-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","article-title":"The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders","volume":"8","author":"Emrich","year":"1985","journal-title":"Journal of Affective Disorder"},{"key":"10.1002\/14651858.CD004052-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the schedule for affective disorders and schizophrenia","volume":"35","author":"Endicott","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD004052-BIB0063|cit63","first-page":"10","article-title":"Valproate use in acute mania and bipolar disorder: An international perspective","volume":"50","author":"Fawcett","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0064|cit64","volume-title":"FDA drug and device product approvals","author":"Food","year":"1995"},{"issue":"10","key":"10.1002\/14651858.CD004052-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1517\/14656566.2.10.1597","article-title":"Anticonvulsants in the treatment of mood disorders: assessing current and future roles","volume":"2","author":"Gilmer","year":"2001","journal-title":"Expert Opinion in Pharmacotherapy"},{"key":"10.1002\/14651858.CD004052-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder","volume":"164","author":"Goodwin","year":"1994","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0067|cit67","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD004052-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomised clinical trials. Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004052-BIB0069|cit69","first-page":"1282","article-title":"Sodium valproate and neural tube defects","volume":"ii","author":"Jeavons","year":"1982","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004052-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis","volume":"282","author":"Juni","year":"1999","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004052-BIB0071|cit71","first-page":"41","article-title":"'Lithium: The Present and the Future' . A Symposium Report from the American Psychiatric Association Annual Meeting, 1994","volume":"56","author":"Keck","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004052-BIB0072|cit72","first-page":"707","article-title":"Neuropsychotropic action of a new antiepileptic: Depramide","volume":"1","author":"Lambert","year":"1966","journal-title":"Annales medico-psychologiques"},{"key":"10.1002\/14651858.CD004052-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1192\/bjp.170.3.264","article-title":"Generalisability of results from randomised controlled trials. A trial of anti-manic treatment","volume":"170","author":"Licht","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0074|cit74","volume-title":"The Maudsley 2001 Prescribing Guidelines","author":"Taylor","year":"2001"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD004052-BIB0075|cit75","first-page":"23","article-title":"Valproate in psychiatric disorders: Literature review and clinical guidelines","volume":"50","author":"McElroy","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004052-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1176\/ajp.149.12.1633","article-title":"Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania","volume":"149","author":"McElroy","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD004052-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1192\/bjp.171.2.113","article-title":"Lithium: Evidence reconsidered","volume":"171","author":"Moncrieff","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004052-BIB0079|cit79","article-title":"Preparing and maintaining systematic reviews","volume-title":"Cochrane Collaboration Handbook","author":"Oxman","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD004052-BIB0080|cit80","article-title":"Antipsychotic drugs for mania","author":"Rendell","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004052-BIB0081|cit81","first-page":"1","article-title":"Medication treatment of bipolar disorder 2000","volume":"Spec. No","author":"Sachs","year":"2000","journal-title":"Postgraduate medicine"},{"key":"10.1002\/14651858.CD004052-BIB0082|cit82","volume-title":"Cochrane Collaboration Handbook","author":"Sackett","year":"1997"},{"key":"10.1002\/14651858.CD004052-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.163.4.514","article-title":"Is there a lithium withdrawal syndrome? An examination of the evidence","volume":"163","author":"Schou","year":"1993","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extra-pyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Suppl"},{"key":"10.1002\/14651858.CD004052-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD004052-BIB0086|cit86","article-title":"Global assessment scale","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Spitzer","year":"1976"},{"issue":"12","key":"10.1002\/14651858.CD004052-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archpsyc.1991.01810360046007","article-title":"Risk of recurrence following discontinuation of lithium treatment in bipolar disorder","volume":"48","author":"Suppes","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004052-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-2007-979553","article-title":"Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial","volume":"29","author":"Thies-Flechtner","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD004052-BIB0089|cit89","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992"},{"key":"10.1002\/14651858.CD004052-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004052.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004052\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:29:35Z","timestamp":1628544575000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004052"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,1,20]]},"references-count":90,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004052","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004052.pub2","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,20]]}}}